16.87

1.00% -0.17

Nurix Therapeutics Inc (NRIX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$17.04

Aprire:

$17.25

Volume 24 ore:

500.15K

Relative Volume:

0.64

Capitalizzazione di mercato:

$1.28B

Reddito:

$54.55M

Utile/perdita netta:

$-193.57M

Rapporto P/E:

-5.8374

EPS:

-2.89

Flusso di cassa netto:

$-181.86M

1 W Prestazione:

-4.09%

1M Prestazione:

-13.93%

6M Prestazione:

-29.44%

1 anno Prestazione:

+68.03%

Intervallo 1D:

$16.75

$17.46

Intervallo di 1 settimana:

$16.56

$18.07

Portata 52W:

$9.9105

$29.56

Nurix Therapeutics Inc Stock (NRIX) Company Profile

Nome

Nurix Therapeutics Inc

Settore

Healthcare (1169)

Industria

Biotechnology (678)

Telefono

(415) 660-5320

Indirizzo

1700 OWENS STREET, SUITE 205, SAN FRANCISCO

Dipendente

286

Cinguettio

Prossima data di guadagno

2024-10-14

Ultimi documenti SEC

NRIX's Discussions on Twitter

Confronta NRIX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NRIX Nurix Therapeutics Inc	16.87	1.28B	54.55M	-193.57M	-181.86M	-2.89
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-10	Iniziato	BTIG Research	Buy
2024-12-06	Iniziato	BMO Capital Markets	Outperform
2024-10-24	Iniziato	UBS	Buy
2024-10-11	Iniziato	Jefferies	Buy
2024-09-06	Ripresa	Robert W. Baird	Outperform
2024-07-31	Iniziato	Truist	Buy
2023-06-26	Ripresa	Oppenheimer	Outperform
2023-03-09	Iniziato	Barclays	Overweight
2023-02-28	Iniziato	Oppenheimer	Outperform
2022-10-11	Iniziato	Morgan Stanley	Equal-Weight
2022-05-31	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-02-10	Iniziato	Wells Fargo	Equal Weight
2021-12-29	Iniziato	H.C. Wainwright	Buy
2021-10-14	Iniziato	SVB Leerink	Outperform
2021-06-04	Ripresa	Robert W. Baird	Outperform
2021-04-30	Ripresa	Piper Sandler	Overweight
2021-04-30	Iniziato	RBC Capital Mkts	Outperform
2021-04-14	Iniziato	Berenberg	Buy
2020-11-19	Iniziato	Robert W. Baird	Outperform
2020-08-18	Iniziato	JP Morgan	Overweight
2020-08-18	Iniziato	Needham	Buy
2020-08-18	Iniziato	Piper Sandler	Overweight
2020-08-18	Iniziato	Stifel	Buy

Mostra tutto

Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie

07:35 AM

Analysts Predict How High Nurix Therapeutics Inc (NRIX) Will Go. - Stocks Register

07:35 AM

Feb 19, 2025

Kymera Therapeutics: Plenty Of Potential, But A Long Way From The Finish Line (KYMR) - Seeking Alpha

Feb 19, 2025

Feb 18, 2025

Nurix Therapeutics: A Story To Monitor (NASDAQ:NRIX) - Seeking Alpha

Feb 18, 2025

Feb 17, 2025

Sumitomo Mitsui Trust Group Inc. Has $14.87 Million Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

Feb 17, 2025

Feb 16, 2025

Nurix Therapeutics (NRIX) Projected to Post Earnings on Thursday - MarketBeat

Feb 16, 2025

Feb 14, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 14, 2025

Strategic Equity Package: Nurix Therapeutics Secures Top Talent with $8.2M Employee Stock Awards - StockTitan

Feb 14, 2025

Feb 13, 2025

Sumitomo Mitsui Trust Group Inc. Raises Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World

Feb 13, 2025

Nurix Therapeutics (NRIX) Projected to Post Quarterly Earnings on Thursday - Defense World

Feb 13, 2025

Feb 12, 2025